Snibe

Shenzhen, China Founded: 1995 • Age: 31 yrs Listed
Developer of laboratory analysis equipment and reagents

About Snibe

Snibe is a publicly listed company based in Shenzhen (China) founded in 1995. The company has 19 employees. Its chief executive, as recorded, is Rao Wei. Its Indian entity Snibe Diagnostic (India) Private Limited reported revenue of β‚Ή156 Cr. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Diversified.

Company details

Developer of laboratory analysis equipment and reagents. It offers clinical laboratory instruments and in vitro diagnostic reagents which include Immunoassay, Biochemistry, Electrolyte, molecular diagnostics, and lab automation integrated system. The lead product MAGLUMI CLIA system delivers fully automated, high-throughput diagnostic testing of multiple pathogens.

  • Headquarters Shenzhen, China
  • Employees 19
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website snibe.com/en
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A
Key Metrics
  • Indian entity revenue
    ₹156 Cr

    FY 2025 · +70% YoY

  • Indian entity net loss
    -₹1.61 Cr

    FY 2025 · -1% margin

  • Indian entity EBITDA
    -₹3.9 Lakh

    FY 2025 · 0% margin

  • Employee Count
    19

Apps and channels of Snibe

its YouTube channel Snibe Diagnostic has 3.44K subscribers and 30 videos.

Snibe Diagnostic
YouTube 3.44K subscribers 30 videos Science & Technology
Open channel

Videos from Snibe

The most watched videos on Snibe's YouTube channel, Snibe Diagnostic (3.44K subscribers). Click a video to play it here.

Snibe MAGLUMI X3 -- Save Your Space without Compromise
10.2K views
Snibe MAGLUMI X6 -- Flexible CLIA Solution For Medium/High-volume Laboratory
7.8K views
Snibe SATLARS T8 -- Total Laboratory Automation Solutions
2.3K views
Snibe MAGLUMI X8 -- Super-fast CLIA Solution
1.6K views

More on Snibe Diagnostic.

Board of directors of Snibe Diagnostic (India) Private Limited (Snibe)

Snibe Diagnostic (India) Private Limited is the primary company behind Snibe. The board of Snibe Diagnostic (India) Private Limited currently have 3 directors; the longest-serving is Lei Zhang, appointed in 2018. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Lei Zhang
DIN 08184326
Director20 Jul 20188 yrs 4 moSnibe Diagnostic (India) Private Limited
Haiyan Liu
DIN 08184327
Director20 Jul 20188 yrs 4 moSnibe Diagnostic (India) Private Limited
Anand Prakash Kushwaha
DIN 08262119
Director20 Oct 20188 yrsSnibe Diagnostic (India) Private Limited

People of Snibe

3 people are tracked at Snibe (3 in leadership); the tracked headcount is 19.

NameRoleGroup
Efe Sullivan Naibe
OwnerLeadership
Rao Wei
CEO & Managing DirectorLeadership
Lisa Fu
General Manager-uzbekistanLeadership
Premium access

Complete people profiles for Snibe

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Snibe

Snibe is a publicly listed company on the SZSE with ticker symbol 300832 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date12 May 2020
  • Listed onSZSE: 300832
  • Listed entityShenzhen New Industries Biomedical Engineering Co. Ltd. Class A
  • Exchange sectorHealth technology
  • ISINCNE100003T39
  • Share price52.76 CNY (+1.36% on the day) · 2026-10-14
  • Market capitalisation40,847,710,974.00 CNY
  • Price to earnings24.1
  • EPS (diluted, trailing year)2.19 CNY
  • Dividend yield2.31%
  • Volume (last session)5,808,440

Financials of Snibe

Figures of Snibe Diagnostic (India) Private Limited, the primary company behind Snibe, for FY 2025. Revenue was ₹156 Cr (+70% year on year). Net loss was -₹1.61 Cr (-1% margin). EBITDA was -₹3.9 Lakh (0% margin). Revenue has grown at a compounded annual rate of +41% over three years and +138% over five years.

  • ₹156 CrRevenue · FY 2025 · +70% YoY
  • -₹1.61 CrNet loss · -1% margin
  • -₹3.9 LakhEBITDA · 0% margin
  • ₹5.00 CrPaid-up capital
  • 19Employees (provident fund records)
  • +41%Revenue CAGR, 3 years
  • +138%Revenue CAGR, 5 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
20254.53B CNY1.62B CNY1.99B CNY
20244.53B CNY1.83B CNY2.15B CNY
20233.92B CNY1.65B CNY1.92B CNY
20223.04B CNY1.33B CNY1.46B CNY
20212.54B CNY973.7M CNY1.17B CNY

Balance sheet, profit and loss, cash flow and ratios of Snibe Diagnostic (India) Private Limited are on its company page.

Premium access

Detailed financial statements for Snibe

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Snibe

The website of Snibe (snibe.com) receives about 6.4K visits a month.

  • Monthly visits
    6.4K

    ▲ 6.7% vs previous month

Similar websites

Websites whose visitors overlap most with Snibe. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
stago-us.com
stago-us.com
100%
#2,145,270–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Snibe

Premium access

Complete news archive for Snibe

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Snibe

Snibe was founded in 1995.

Snibe is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.

Rao Wei is the CEO of Snibe, as recorded in our data.

Snibe has 19 employees.

The primary company behind Snibe, Snibe Diagnostic (India) Private Limited, reported revenue of β‚Ή156 Cr for FY 2025, up 70% year on year.

Developer of laboratory analysis equipment and reagents. It offers clinical laboratory instruments and in vitro diagnostic reagents which include Immunoassay, Biochemistry, Electrolyte, molecular diagnostics, and lab automation integrated system. The lead product MAGLUMI CLIA system delivers fully automated, high-throughput diagnostic testing of multiple pathogens.

Yes, Snibe is publicly traded on SZSE under the ticker symbol 300832.

Snibe operates through Snibe Diagnostic (India) Private Limited.

The legal entities of Snibe currently have 4 directors, including Lei Zhang, Haiyan Liu, Anand Prakash Kushwaha and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available